A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
168
mentions
- X 136
- News 14
- Facebook 10
- Instagram 3
- +3 more
PubHawk tracks social media discussions for 1 article by authors named Alexander Kainz.
Mentions
Extended reach
Total likes
Video views
Tracked by PubHawk
From PubMed
Searching PubMed…